Clinical Edge Journal Scan

Interval breast cancer has higher hazard for breast cancer death than screen-detected breast cancer


 

Key clinical point: Interval breast cancers (IBC) were six times more likely to be grade III and had 3.5 times increased hazards of death compared with screen-detected cancers (SBC).

Major finding: Breast cancer–specific mortality was significantly higher for IBC compared with SBC cancers (hazard ratio [HR] 3.55; 95% CI, 2.01-6.28; P < .001).

Study details: A cohort study of 69,000 women aged 50-64 years

Disclosures: Dr Hu is the holder of a Manitoba Medical Services Foundation (MMSF) Allen Rouse Basic Science Career Development Research Award.

Source: Niraula, Saroj, MD, MSc, et al. JAMA Netw Open. 2020;3(9):e2018179. doi:10.1001/jamanetworkopen.2020.18179

Recommended Reading

Divergent findings with paclitaxel and nab-paclitaxel in TNBC
MDedge Hematology and Oncology
Cancer disparities: One of the most pressing public health issues
MDedge Hematology and Oncology
The scope of under- and overtreatment in older adults with cancer
MDedge Hematology and Oncology
Radiotherapy planning scans reveal breast cancer patients’ CVD risk
MDedge Hematology and Oncology
Restarting breast cancer screening after disruption not so simple
MDedge Hematology and Oncology
AI algorithm on par with radiologists as mammogram reader
MDedge Hematology and Oncology
Study supports multigene panel testing for all breast cancer patients with second primary cancers
MDedge Hematology and Oncology
Beyond baseline, DBT no better than mammography for dense breasts
MDedge Hematology and Oncology
Women 70 and older are divided on age-based guidelines for breast cancer treatment
MDedge Hematology and Oncology
Ductal carcinoma in situ increases risk of dying from breast cancer by threefold
MDedge Hematology and Oncology